None listed
Conditions
Brief summary
The BALTIC HEART study designed as international eHealth initiative in “ICT for Health” project part-financed by European Union Interreg program. Study aims to assess effects of telemedicine and distance learning applications in the prevention of further hospitalisations in patients with chronic heart failure. Transnational cooperation in this study opens the mind for innovative ways of eHealth deployment in different health conditions and for sharing knowledge and resources across borders.
Interventions
1 group: the standard home care program plus a 6 month
telemonitoring program and plus 6 month tele-education program; Telemonitoring involves: self blood pressure measurement and body wheight monitoring every day on routine basis, using GSM service; Tele-education program involves training on webbased education platform on individual risk factors and its control; Patients on tele-education have to complete 1 hour basic education program "SALUDA" and every 3 week period will receive educationa
1 group: the standard home care program plus a 6 month telemonitoring program and plus 6 month tele-education program; Telemonitoring involves: self blood pressure measurement and body wheight monitoring every day on routine basis, using GSM service; Tele-education program involves training on webbased education platform on individual risk factors and its control; Patients on tele-education have to complete 1 hour basic education program "SALUDA" and every 3 week period will receive educational messages on individual risk factors. Telemonitoring and tele-education programs are delivered simultaneously at the same time. 2 group: the standard home care program plus plus 6 month teleeducation program. Teleeducation program involves training on webbased education platform on individual risk factors control.
Sponsors
European Commission
Study design
Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Written informed consent obtained. 2. Male and female patients over 18 years of age. 3. Chronic heart failure diagnosed at least before study involvement. Treated with relevant long-term oral treatment. 4. Relevant NYHA II-III symptoms at screening and at baseline.
Exclusion criteria
1. NYHA I or IV 2. Therapeutic education impossible 3. Severe renal insufficiency (serum creatinine >450 mmol/l [5.0 mg/dl]) or on dialysis 4. Severe anaemia (blood haemoglobin <10 g/dl) at screening 5. Other serious diseases limiting life expectancy considerably (e.g. end-stage cancer)
Outcome results
None listed